Vol 15, No 1S (2014)

Table of Contents

Editorial

The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro
HTML PDF
3-4

Original research

Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro
HTML PDF
5-14
Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro
HTML PDF
15-26